BIOCHEMICAL
Vol. 47, No. 5, 1972
PREFERENTIAL
BINDING DURING
OF 2-ACETYLAMINOFLUORENE
EARLY
Charles Cancer Research of Biochemistry, Received
May 1, 19’72
Summary
:
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
STAGES
rRNA
OF HEPATOCARCINOGENESIS
C. Irving
Laboratory, University
TO RAT LIVER
and Richard
A. Veazey
Veterans Administration of Tennessee, Memphis,
Hospital, and Department Tennessee 38104
During continuous feeding of 2-acetylaminofluorene-9J4C (AAF-9-14C) under conditions known to induce a high incidence of liver tumors ln male rats, there is preferential binding of the carcinogen to liver rRNA. Furthermore, simultaneous administration of 3-methylcholanthrene, which inhibits liver tumor induction by AAF, resulted in a 35-40s decrease in binding to liver rRNA as opposed to a 50% increase in the binding of AAF-9J’C to liver tRNA. These data support the concept that binding of AAF to liver rRNA might be involved in hepatocarcinogenesis. Administration metabolite
of the carcinogen
to rats leads to base substitution
ment of 2-acetylaminofluorenyl position
of guanine
greater
than that of rRNA
speculation
injection
(4,s).
of AAF
the continuous
additional
experiments
or N-hydroxy-AAF. feeding
rRNA during
@ 1972, by Academic
Press, Inc.
is several-fold
of AAF-9-I’C
liver
or N-
tRNA has led to of action
of
in the interpretation tumors
of hepatocellular
for 8-12 weeks.
following
a
carcinoma As a result
of binding
was preferential
stages of hepatocarcinogenesis.
attach-
at the C-8
to tRNA in the mechanism
but that there
1159 Copyright
tRNA
(6), we found that there was no correlation
initial
by covalent
to rat liver
Induction
of these compounds
or its N-hydroxy
primarily
injection
binding
of binding
acids
One fact that must be considered
tRNA and hepatocarcinogenicity
to rat liver
of liver
a single
The preferential
(AAF)
residues,
of these data is that rats do not develop
requires
to liver
nucleic
radioactivity
or DNA following
the involvement
these hepatocarcinogens of the significance
The specific
(1,2,4).
regarding
in liver
and 2-aminofluorenyl
(l-3).
hydroxy-AAF-9J4C
single
2-acetylaminofluorene
binding
of
of AAF of AAF
Vol. 47, No. 5, 1972
Methods
BIOCHEMICAL
: J4C was fed to Holtzman
2-Acetylammofluorene-9 solution
in dimethylsulfoxide/corn
isolated
as follows.
a .pellet
3 hours Ribosomal
rpm
potassium
converted
determined
to equivalent
by liquid
picomoles
scintillation
were
yielding
(7).
S1 was centrifuged
pfor
(P2) and supernatant
was isolated
from S2, then puri-
salt and re-conversion (dpm carbon-14 residues
(S2).
to the
bound per mg nucleic bound per mg)
were
(2).
and Discussion:
DNA from
male
acids
with 25 ml of cold 6% sodium
of fluorenyl
counting
as a
SS-34 rotor),
to give a pellet
radioactivities
administration
DNA of male rats increased
AAF,
P1 was stirred
from P2 (7) and tRNA
The specific
Upon continuous liver
rpm (Sorvall
to the cetyltrimethylammonium
salt (8).
Nucleic
i.p.
in cold 0.9% NaCl and the homo-
at 10,000
No. 40 rotor)
rats or injected
vol/vol).
and DNA was isolated
(Spinco
RNA was obtained
fied by conversion
Results
(Sl).
for 45 minutes
at 38,000
(l/6,
was homogenized
for 30 minutes
(Pi) and supernatant
aminosalicylate
oil solution
The liver
genate was centrifuged
acid,
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
2-8 weeks.
binding
to liver
rats (300-400
both sexes. at l-3
to tRNA
of female
8 weeks.
DNA increased
bound to liver
rRNA.
The binding
slowly
pmoles/mg
(loo-150
In male rats,
by 2 weeks,
of AAF-92%
to liver
rRNA
1160
tumor
induction
the value
obtained
by in
tRNA was much less in
tRNA of male rats occurred
2-8 weeks. pmoles/mg)
was observed binding
to
pmoles/mg
of bound carcinogen
to liver
then fell gradually to liver
off at 300-400
to liver
to liver
from
sex difference
of the carcinogen
but reached
Binding
of AAF-9J4C
was constant
significant
rRNA
more
are resistant
tRNA) but the amount
at 100-150
rat liver
which
binding
then leveled
at 4-8 weeks.
binding
The most
to 350 pmoles/mg
rats,
pmoles/mg
and remained
cinogen
In female
The maximum
rapidly,
8 weeks.
for 2 weeks,
pmoles/mg)
days (200-250
of AAF-9J4C,
Binding
of AAF-9%
between
1 day and
in the amount rRNA
to 100-150
of female
declined
of the car-
increased pmoles/mg
rats increased
rapidly by very
BIOCHEMICAL
Vol. 47, No. 5, 1972
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
.. rRNA:
DNA
tRNA:rRNA
2
0 Weeks
12345676 Weeks
Figure
Fed 0.04%
and reached
data presented
in Fig. binding
The specific
radioactivity
1 day of feeding ratios
were
the apparent
The specific
value of 100-150
1A illustrate
of AAF-914C
change from
an initial
tRNA to preferential
In male rats,
at 1 day the tRNA/DNA
respectively.
binding
However,
after
of the carcinogen
of tRNA relative to rRNA
For female
rats,
(1 day)
1161
0 from
to rRNA.
or DNA after and tRNA/
these ratios
were
one week of feeding
AAF-
to liver
tRNA disappeared.
to that of DNA was about 0.4-O.
was 0.4-l.
The
binding
than that of rRNA
and 3.0 (tRNA/rRNA).
that relative
at 4-8 weeks.
tRNA was greater
to rats.
preferential
pmoles/mg
the dramatic to rat liver
of liver
3.6 and 3.1,
radioactivity
2-8 weeks while
and female (------) rats were fed a grain diet containing 4 animals were sacrificed and hepatic At weekly intervals, sulfotransferase was determined (9).
AAF-9-‘4C
1.6 (tRNA/DNA) 9”C,
6
AAF
AAF-6-14C
a maximum
preferential
rRNA
0.04%
and female (-------) ra t s were fed a grain diet (14) con1. (A) Male (-) taining 0.04% AAF-9-14C (1.91 dpm/pmole). At 1 and 3 days, then at weekly intervals for 8 weeks, 2 animals were sacrificed and tRNA, rRNA The specific radioactivity (dpm/mg) and DNA were isolated from the liver. of each nucleic acid was determined and the data expressed as the ratio of specific radioactivities indicated. (B) Male (-) 0.04% AAF. N-hydroxy-AAF
slowly
6
4 Fed
2-8 weeks
(Fig.
5 from 1A).
Vol. 47, No. 5,1972
BIOCHEMICAL
AAF-N-sulfate,
an extremely
hydroxy-AAF
by the action
homogenates
(9).
early
of AAF-9%
binding
activity in hepatic
(Fig.
1B).
1) suggest
gens to liver
in the soluble
fraction
N-
of rat liver
drop in the specific
during
parallels
radio-
the decrease
continuous
to a significant
feeding
of AAF
extent in the binding
DNA (10) and the results
may not be involved
from
for most of the
precisely
observed
is not involved
that AAF-N-sulfate
is formed
is responsible
to DNA and rRNA
to rat liver
of AAF,
The dramatic
sulfotransferase
AAF-N-sulfate
presented
in binding
here
of these carcino-
rRNA.
Approximately
10% of the labeled
DNA after administration pletely
tRNA.
IA) relative
of AAF or N-hydroxy-AAF (Fig.
metabolite
that AAF-N-sulfate
to liver
N-hydroxy-AAF
to rats (Fig.
reactive
of a sulfotransferase
We believe
of tRNA
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
disappears
of a single
from
liver
rRNA
carcinogen
remained
dose of AAF-9-%, by 4 weeks
(2).
firmly
whereas
bound to liver the label
Bound carcinogen
com-
(single
dose)
100
P p 75 ii E .-iix $ 50 2 2 s ,j
25
Weeks
Figure
after
Injection
of
AAF-Q-14C
2. Twelve male rats (180-200 g) were each given a single i.p. injection of 2-acetylaminofluorene -9 -14C (dose, 30 mg/kg; specific radioactivity, 8.90 dpm/pmole). At 1, 3, 7, 14, 28 and 56 days, 2 animals were sacrificed and liver tRNA, rRNA and DNA were isolated and the specific radioactivities of the nucleic acids were determined. The ordinate is expressed as percent of the maximum binding (attained at day 1) for each nucleic acid. Values for the amount of carcmogen bound at day 1 were: tRNA, 116 pmoles/mg; rRNA, 49; and DNA, 26.
1162
Vol. 47, No. 5,1972
disappears
from
BIOCHEMICAL
liver
tRNA at a much faster
in Fig.
2, and is completely
tration
of AAF-9%.
found here (Fig.
Normal
to note the greatly liver
rRNA
that disappearance
half-life
from
(2).
and tRNA
each have half-lives
of bound carcinogen
from
are unknown,
of approximately
was
to 3 days for rRNA
involved
(or turnover
is not due simply
after adminis-
radioactivity
in contrast
Mechanisms
removal
or DNA as seen
by 2 weeks
tRNA and rRNA
accelerated
rRNA
of the tRNA-bound
3 and 14 days),
reported
bound derivatives
rate than from
( < 1% of maximum)
from data between
2) and previously
of the carcinogen interesting
removed
The biological
1.5 days (calculated
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
in the removal but it is of) the tRNA.
5 days (1 l-13)
to normal
turnover
of the
rRNA and tRNA. 3-Methylcholanthrene (see ref.
(MC) inhibits
14) and also inhibits
liver
the binding
TO RAT LIVER
pmoles Nucleic
in male rats by AAF
to rat liver
rRNA and DNA
I
OF 3-METHYLCHOLANTHRENE OF AAF-92%
induction
of AAF-9-14C
TABLE
INFLUENCE
tumor
bound/mg
(MC) ON THE BINDING NUCLEIC
nucleic
ACIDS?
acid
acid AAF-9-I% diet
AA-99”G4C + MC diet
Influence of MC (%)
DNA
358 I!I 30
232 f 29
- 36
rRNA
328 + 24
200 f
6
- 39
tRNA
148 f 10
224 f
9
+158
a_Male rats were fed a grain diet containing 0.04% AAF-914C (1.91 dpm/pmole) without or with MC (O.OOSp7,) for 2 weeks before sacrifice. Mean + S.E. (3 rats). The average amounts of AAF-9% ingested during the 2-week period were: AAF-91% diet, 0.32 mmoles; and AAF-9% + MC diet, 0.40 mmoles.
1163
so
BIOCHEMICAL
Vol. 47, No. 5, 1972
following
a single
injection
(0.005%)
was fed simultaneously
to liver
rRNA
to liver
tRNA was increased
rat. initial
of the carcinogen
several
lines
to liver
2-5 weeks
almost
50% under of evidence
of AAF-9
of carcinogen
feeding,
phase of hepatocarcinogenesis
by AAF
for 2 weeks,
40% (Table
suggest
binding
When 3-methylcholanthrene
1).
these conditions
tRNA is not correlated
The preferential
(14).
with AAF-9-Z4C
and DNA was inhibited
Thus, AAF-914C
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
binding
of AAF-9-1”C
However,
the binding
(Table
1).
that the extent of covalent
with hepatocarcinogenicity J’C to liver
rRNA
the time at which begins
(15,16),
binding
of AAF
in the male the early
of
in the
rat during
the
proliferative
may be of significance.
Acknowledgment: These from
the National
References 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16.
studies
were Cancer
supported
in part by USPHS Research
Grant
CA -05490
Institute.
:
Irving, C. C. , Veazey, R. A. and Williard, R. F. Cancer Res. 27: 173 (1967). Irving, C. C. and Veazey, R. A. Cancer Res. 29: 1799 (1969). Kriek, E. , Miller, J. A., Juhl, U. and Miller, E. C. Biochemistry 6: 177 (1967). Agarwal, M. K. and Weinstein, I. B. Biochemistry 9: 503 (1970). Fink, L. M., Nishimura, S. and Weinstein, I. B. Biochemistry 9: 946 (1970). Irving, C. C. and Veazey, R. A. Proc. Am. Assoc. Cancer Res. 12: 54 (1971). Irving, C. C. and Veazey, R. A. Biochim. Biophys. Acta 166: 246 (1968). Irving, C. C., Janss, D. H. and Russell, L. T. Cancer Res. 31: 387 (1971). DeBaun, J. R., Miller, E. C. and Miller, J. A. Cancer Res. 30: 577 (1970). L. T. Chem. -Biol. Interactions 1: Irving, c. c., Veazey, R. A. and Russell, 19 (1969/70). Hanoune, J. and Agarwal, M. K. FEBS Letters 11: 78 (1970). Hirsch, C. A. and Hiatt, H. H. J. Biol. Chem. 241: 5936 (1966). Loeb, J. N., Howell, R. R., and Tompkins, G. M. Science 149: 1093 (1965). Irving, C. C., Peeler, T. C., Veazey, R. A. and Wiseman, R., Jr. Cancer Res. 31: 1468 (1971). Farber, E. Cancer Res. 16: 142 (1956). Jackson, C. D. and Irving, C. C. Cancer Res. 32: in press.
1164